How effective is serum FGL1 measurement in assessing disease activity: A cross-sectional study in rheumatoid arthritis

This publication has 12 references indexed in Scilit:

• Regulatory Role of FGL ‐1 in Interorgan Communication by Controlling T Cell Homeostasis During the Onset of Sjögren Disease
  Arthritis & Rheumatology, 2025
• Unlocking therapeutic potential: Targeting lymphocyte activation Gene-3 (LAG-3) with fibrinogen-like protein 1 (FGL1) in systemic lupus erythematosus
  Journal of Translational Autoimmunity, 2024
• FGL1-LAG3 axis impairs IL-10-Producing regulatory T cells associated with Systemic lupus erythematosus disease activity
  Heliyon, 2023
• Serum fibrinogen-like protein 1 as a novel biomarker in polycystic ovary syndrome: a case–control study
  Journal of Endocrinological Investigation, 2022
• RETRACTED ARTICLE: Exosomes derived from Fibrinogen-like protein 1-overexpressing Bone Marrow-Derived Mesenchymal Stem Cells ameliorates rheumatoid arthritis
  Bioengineered, 2022
• Fibrinogen-like protein 1 (FGL1): the next immune checkpoint target
  Journal of Hematology & Oncology, 2021
• Innate immunity drives pathogenesis of rheumatoid arthritis
  Biomedical Journal, 2021
• Fibrinogen-like Protein 1 Is a Major Immune Inhibitory Ligand of LAG-3
  Cell, 2019
• Biomarkers for rheumatoid arthritis: From molecular processes to diagnostic applications-current concepts and future perspectives
  Immunology Letters, 2017
• Fibrinogen-like protein 1, a hepatocyte derived protein is an acute phase reactant
  Biochemical and Biophysical Research Communications, 2008